Affiliation:
1. Federal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases
Abstract
Almost all known stress stimuli, including inflammatory agonists, chemotherapeutic agents and saturated fatty acids, cause the synthesis of ceramide and its metabolites. In recent studies, it has been shown that excessive synthesis of ceramides causes the development of various metabolic diseases, such as obesity, diabetes and cardiovascular diseases. Currently, the role of ceramids in the development of obesity and diabetes has been studied quite well. At the same time, studies devoted to the study of lipid data in the development of cardiovascular disease are not large. In this review, we generalize the data on this new class of bioactive lipids for understanding their role in the development of cardiovascular diseases.
Subject
Biochemistry (medical),Medical Laboratory Technology,General Medicine
Reference40 articles.
1. Laaksonen R., Ekroos K., Sysi-Aho M., Hilvo M., Vihervaara T., Kauhanen D. et al. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. European Heart Journal. 2016; 37: 1967-76.
2. Chatham J.C., Young M.E. Metabolic remodeling in the hypertrophic heart: fuel for thought. Circ. Res. 2012;111: 666-8.
3. Klevstig M., Ståhlman M., Lundqvist A., Scharin Täng M., Fogelstrand P. et al. Targeting acid sphingomyelinase reduces cardiac ceramide accumulation in thepost-ischemic heart. J. Mol. Cell. Cardiol. 2016;93:69-72.
4. Futerman A.H., Riezman H. The ins and outs of sphingolipid synthesis. Trends Cell Biol. 2005;15(6):312-8.
5. Perry R.J, Ridgway N.D. Molecular mechanisms and regulation of ceramide transport. Biochim. Biophys. Acta. 2005;1734(3):220-34.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献